manufacturers of glp-1 drugs Market Overview: Agonists and the Obesity Market | Blog GLP-1 Drugs from the Gray
Description
doi:10.1248/bpb.31.925
found that liraglutide treatment led to reductions in FBG and leptin, improving IR and demonstrating favorable metabolic effects in women with PCOS 52 (Table 3)
These results were achieved alongside reduced-calorie diets and increased physical activity
Tanokashira D, Fukuokaya W, Taguchi A
Allan KC, Joo JH, Kim S, et al
